Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.3 SEK | -1.12% |
|
-7.99% | -30.81% |
Jun. 19 | Ziccum Signs Evaluation Agreement with Recode Therapeutics for LaminarPace mRNA Study | CI |
Apr. 29 | Ziccum AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- ZICC Stock
- News Ziccum AB
- MarketScreener Strategies